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Abstract
Background: Host defence peptides are a diverse group of small, cationic peptides and are important elements
of the first line of defense against pathogens in animals. Expression and functional analysis of host defense
peptides has been evaluated in chicken but there are no direct, comprehensive comparisons with all gene family
and individual genes.
Results: We examined the expression patterns of all known cathelicidins, β-defensins and NK-lysin in multiple
selected tissues from chickens. CATH1 through 3 were predominantly expressed in the bone marrow, whereas
CATHB1 was predominant in bursa of Fabricius. The tissue specific pattern of β-defensins generally fell into two
groups. β-defensin1-7 expression was predominantly in bone marrow, whereas β-defensin8-10 and β-defensin13
were highly expressed in liver. NK-lysin expression was highest in spleen. We synthesized peptide products of these
gene families and analysed their antibacterial efficacy. Most of the host defense peptides showed antibacterial activity
against E.coli with dose-dependent efficacy. β-defensin4 and CATH3 displayed the strongest antibacterial activity
among all tested chicken HDPs. Microscopic analyses revealed the killing of bacterium by disrupting membranes
with peptide treatment.
Conclusions: These results demonstrate dose-dependent antimicrobial effects of chicken HDPs mediated by
membrane damage and demonstrate the differential tissue expression pattern of bioactive HDPs in chicken and
the relative antimicrobial potency of the peptides they encode.
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Background
Bacterial infections in chickens are important not only
for the health and productivity of the animals but also as
a reservoir of foodborne human pathogens such as
Salmonella enterica. Innate immunity is important in
controlling bacterial infection, particularly at mucosal
surfaces such as the gastrointestinsal, respiratory and
reproductive tracts. Innate immune agents include
antimicrobial secretions such as lysozyme, mucocilli-
ary clearance, the acid environment of the gizzard
and proventriculus and tight cellular junction at
epithelial layers [1].
Host defense peptides (HDPs) are a diverse group of
small, cationic peptides present in A wide variety of
organisms including both animals and plants [2–6].
HDPs are an important first line of defense, particularly
in those species whose adaptive immune system is lack-
ing or primitive. A majority of HDPs are strategically
synthesized in the host phagocytic and mucosal epithelial
cells that regularly encounter microorganisms from the
environment. Mature HDPs are broadly active against
Gram-negative and Gram-positive bacteria, mycobacteria,
fungi, viruses and even cancerous cells [7–9]. Several
classification schemes have been proposed for AMPs;
however, most AMPs are generally categorized into four
clusters based on their secondary structures: peptides with
a linear α-helical structure [10–12], cyclic peptides with a
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β-sheet structure [13–17], peptides with a β-hairpin struc-
ture [18], and peptides with a linear structure [19, 20].
It has become clear that HDPs are important and sig-
nificant components of host defence against infection.
The killing of bacteria appears to be very fast, ranging
from 10 to 30 min for killing of S. enteritidis [21] and
30–60 min for killing of E.coli [22]. We have demon-
strated chicken NK-lysin to destroy E. coli cell mem-
branes within 5 min [23]. Furthermore, HDPs kill
bacteria primarily through physical electrostatic interac-
tions and membrane disruption. Therefore, it is difficult
for microbes to gain resistance to HDPs [7, 24]. At the
same time, most HDP’s have the capacity to recruit and
activate immune cells and facilitate the resolution of
inflammation [24, 25]. Therefore, it is not easy to differ-
entiate therapeutic potential of HDPs, particularly
against antibiotic-resistance bacteria. A highly promising
approach to overcome drug resistance is to explore and ex-
ploit the huge diversity of innovative bioactive-engineered
molecules provided by nature to fight pathogens. These
include HDPs, natural products involved in the defense
systems. So, with their obvious potential as novel thera-
peutic agents, understanding the HDPs, including the rela-
tionships between structure and mode of action of these
molecules, is essential for the development of novel
peptide-based antibiotics and immunotherapeutic tools.
Three major groups of HDPs, namely cathelicidins
(CATH), defensins and NK-lysin are present in vertebrate
animals. Defensins constitute a large family of small,
cysteine rich, cationic peptides that are capable of killing
a broad spectrum of pathogens [26–29]. Vertebrate
defensins are classified into three subfamilies, the α-, β-,
and θ-defensins, characterized by different spacing of the
six conserved cysteines. Cathelicidins are recognized by
the presence of cathelin-like domains. The signal peptide
and cathelin-like domains are well conserved across spe-
cies, but the mature peptide sequences at the C-terminal
regions are highly diverse [30]. Whereas the defensin
structure is based on a common β-sheet core stabilized
by three disulfide bonds [2], CATH s are highly hetero-
geneous. NK-lysin is a member of the saposin-like pro-
tein (SALIP) family, and is orthologous with human
granulysin with a α-helical structure [9].
The first avian HDPs discovered were β-defensins from
chicken and turkey, reported in the mid 1990-’s [31],
and increasing information about HDPs in other avians
species is becoming available [32]. The sequencing of
the chicken (Gallus gallus) genome revealed the pres-
ence of a cluster of 14 different genes on chromosome 3
coding for avian defensins (AvBD) and designated then
as AvBD1 to -14 [33, 34] and 4 CATHs densely clus-
tered at the proximal end of chromosome 2 [35, 36].
NK-lysin was recently mapped to the distal end of
chromosome 22 [37].
The highly inbred Leghorn Ghs-6 line has been used in
many studies of immune function, including serving as a
parental line of an advanced intercross line used to iden-
tify the association of genetic variants in the AvBD gene
cluster with colonization of the cecum with Salmonella
enterica serovar Enteritidis [38]. The bursa of Fabricius, a
specialized immune organ in birds, arises from bursal epi-
thelial cells around embryonic day 4, reaches a maximum
size at 6–12 weeks after hatching [39] and previously
demonstrated high expression of several of AvBDs [34].
The gene expression and antibacterial efficacy of all four
CATH and several AvBDs has been evaluated individually,
but there are no reports comparing the full spectrum of
tissue expression and antimicrobial activity of chicken
HDPs concordantly. Here, we have examined expression
patterns of 14 AvBD, 4 CATH and NK-lysin with the
highly inbred Leghorn Ghs-6 line and compared the anti-
microbial activity of the peptides encoded against E.coli.
Morphological change of E.colimembranes by CATH pep-
tide treatment was also examined.
Methods
Birds
Chicks of the highly inbred Leghorn Ghs-6 line were pro-
duced and maintained in the Poultry Genetics Program at
Iowa State University (Ames, IA). Birds were raised in light-
and temperature-controlled pens with wood-shaving bed-
ding and continual access to water and food meeting all
NRC nutritional requirements. At 7 weeks of age, birds were
euthanized according to the approved Institutional Animal
Care and Use Committee protocol (Log #4-03-5425-G) and
tissues immediately dissected. Bursa of Fabricius, thymus,
spleen, bone marrow, cecal tonsil, duodenal loop, and liver
tissue were collected. Samples consisting of either the entire
tissue, or sections totalling approximately 1.0 cubic cm from
larger tissues were harvested. The cecal tonsil included the
lymphoid aggregates and surrounding tissue at the intersec-
tion of the two ceca and the gastrointestinal tract. Bone
marrow was collected by expressing the marrow from both
tibias of each bird with a narrow sterile wooden rod. Tissues
were placed into RNAlater until used for isolation of
mRNA.
RNA extraction and quantitative reverse-transcription
polymerase chain reaction (RT-PCR)
RNA extraction was performed using RNeasy Mini Kit
(Qiagen) according to the manufacturer’s instructions.
Total RNA samples were extracted from 5 birds tissues and
used as a template for reverse transcription. cDNA was ob-
tained by reverse transcriptase SuperScript® III First-Strand
Synthesis System using 2 μg total RNA. The relative abun-
dance of mRNA from genes was assessed by real time
reverse-transcription (RT)-PCR using a Lightcycler 480
(Bio-Rad) and a Lightcycler 480 SYBR Green I master (Bio-
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Rad). Primer pairs specific for the amplification of AvBD,
cathelicidin and NK-lysin genes are shown in Additional file
1: Table S1. PCR products were subjected to melt curve
analysis and sequenced to confirm amplification of the cor-
rect gene. Data were analyzed by ddCt method. The mean
threshold cycle value (Ct) of each sample was normalized
to the internal control, GAPDH, and the expression profiles
were obtained by comparing normalized Ct value with the
calibrator sample, in which the gene exhibited the lowest
expression level. Each analysis was performed in triplicate.
Quantification of each sample was calculated with the cycle
threshold values and standard curve information using the
Lightcycler 480 version 1.5.0 software.
Peptide synthesis
Nineteen synthetic linear peptides (Table 1) correspond-
ing to chicken defensins, cathelicidins and NK-lysin, were
synthesized and purified to >95 % purity grade through
reverse-phase high-pressure liquid chromatography
(Abclon, Seoul, Korea). Lyophilized peptide (1 mg each)
was stored in desiccant at −20 °C and dissolved in phos-
phate buffer (pH 7.2) before use.
Cell viability analysis of Escherichia coli after treatment
with peptides
Gram-negative bacteria, Escherichia coli ATCC 25922,
were purchased from Korean Collection for Type
Culture and tested against each peptide. Cell viability
analysis was carried out as previously reported [23].
Briefly, 6 × 106 colony–forming units (CFU)/ml bacteria
suspensions (90 μl) were placed into 96 well plates,
followed by the addition of 10 μl of serial diluted peptide
(final 0, 0.5, 1, 2.5, 5 μM) in triplicate. After 2 h incuba-
tion at 37 °C, equal volume of BacTiter-Glo™ Reagent
(Promega) was added, and incubated for 5 min after
which luminescence was measured with GloMax-Multi
Detection System (Promega).
Detection of damaged E. coli membranes after treatment
with synthetic cathelicidin peptides
To visualize E. coli membrane damage, 6.5 × 106 CFU
of E. coli were incubated with 5 μM CATH1, CATH2,
CATH3, or CATHB1 in 10 mM phosphate buffer
(pH 7.0), respectively, at 37 °C for 2 h, and the mem-
branes were observed by confocal laser scanning
microscopy (Carl Zeiss, Oberkochen, Germany) after
staining with the LIVE/DEAD BacLight bacterial
viability kit (Invitrogen) according to the manufac-
turer’s protocol.
Scanning electron microscopic analysis
To visualize membrane damages of E. coli, 6.5 ×
106 CFU of E. coli were incubated with 5 μM CATH1,
CATH2, CATH3, or CATHB1 peptides at 37 °C for
Table 1 Sequences and properties of peptides used in this study
Name Length (aa) Composition Mw (g/mol) Net charge Hydrophobic ratio
AvBD1 40 GRKSDCFRKSGFCAFLKCPSLTLISGKCSRFYLCCKRIWG 4567.55 7.7 32
AvBD2 39 RDMLFCKGGSCHFGGCPSHLIKVGSCFGFRSCCKWPWNA 4324.14 3.9 36
AvBD3 36 TATQCRIRGGFCRVGSCRFPHIAIGKCATFISCCGR 3877.62 5.8 33
AvBD4 37 RYHMQCGYRGTFCTPGKCPYGNAYLGLCRPKYSCCRW 4341.08 5.8 24
AvBD5 37 GLPQDCERRGGFCSHKSCPPGIGRIGLCSKEDFCCRS 4000.59 1.8 24
AvBD6 38 SPIHACRYQRGVCIPGPCRWPYYRVGSCGSGLKSCCVR 4216.96 5.8 32
AvBD7 37 RPIDTCRLRNGLCFPGICRRPYYWIGTCNNGIGSCCAR 4307.05 4.7 32
AvBD8 41 NNEAQCEQAGGICSKDHCFHLHTRAFGHCQRGVPCCRTVYD 4593.16 0.1 24
AvBD9 42 ADTLACRQSMGSCSFVACRAPSVDIGTCRGGKLKCCKWAPSS 4353.13 3.7 36
AvBD10 42 PDTVACRTQGNFCRAGACPPTFTISGQCHGGLLNCCAKIPAQ 4309.01 1.8 38
AvBD11 39 RDTSRCVGYHGYCIRSKVCPKPFAAFGTCSWRQKTCCVD 4431.14 4.8 28
AvBD12 44 PDSCNHDRGLCRVGNCNPGEYLAKYCFEPVILLCCKPLSPTPTKT 4841.64 0.8 36
AvBD13 37 SDSQLCRNNHGHCRRLCFHMESWAGSCMNGRLRCCRF 4373.03 4 24
AvBD14 37 DTVTCRKMKGKCSFLLCPFFKRSSGTCYNGLAKCCRP 4151 6.7 30
CATH1 28 PVRVKRVWPLVIRTVIAGYNLYRAIKKK 3338.14 8 53
CATB1 40 PIRNWWIRIWEWLNGIRKRLRQRSPFYVRGHLNVTSTPQP 5028.86 7.1 45
CATH2 34 PVLVQRGRFGRFLRKIRRFRPKVTITIQGSARFG 4014.84 10 44
CATH3 31 PVRVKRFWPLVPVAINTVAAGINLYKAIRRK 3547.35 7 61
cNK3 30 PDEDAINNALNKVCSTGRRQRSICKQLLKK 3399.95 3.9 30
Molecular weight, net charge at pH7 and hydrophobic ratio were calculated using Peptide property calculator (http://www.innovagen.proteomics-tools)
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5 min. After incubation, the bacteria were fixed with 2 %
glutaraldehyde, washed, mounted, and damaged mem-
branes were observed by a Field-Emission Scanning
Electron Microscope (Carl Zeiss Inc.).
Statistical analysis
GraphPad prism software was used for cell viability data
analyses and gene expression analysis and data were
expressed as mean ± SD. Statistical significance between
groups or conditions was analysed by two-way or one-
way ANOVA followed by Bonferroni’s post hoc test
unless stated otherwise. Differences were considered to
be statistically significant when p < 0.05.
Results
Tissue expression patterns
Quantitative RT-PCR was performed to examine the
expression patterns of CATH, AvBD and NK-lysin genes
in various chicken tissues. The chicken AvBDgene family
has a unique expression pattern. cAvBD1 through 7 are
predominantly expressed in bone marrow and weakly
expressed in thymus. AvBD5 is an exception with strong
expression in the thymus. The other AvBDs, AvBD8
through 10 and AvBD13 are predominantly expressed in
liver. AvBD11, AvBD12 and AvBD14 are expressed in all
tissues tested (Fig. 1). Chicken CATH1, -2, and -3 are
predominantly expressed in the bone marrow and to a
lesser extent in bursa of Fabricius and thymus. CATHB1,
however, showed abundant expression in bursa of Fabricius
with low levels of expression in thymus and cecal tonsils.
NK-lysin was predominantly expressed in spleen and
in the duodenal loop, with lesser expression in thy-
mus and bone marrow.
Antimicrobial activity of chicken HDPs
To address and compare the relative antibacterial activity
of chicken HDPs, 14 AvBD, 4 CATH and one NK-lysin
peptide were synthesized and tested for antimicrobial
Fig. 1 Tissue expression of chicken HDPs. Quantitative RT-PCR analysis of CATH, AvBD and NK-lysin gene expression in chicken tissues. The relative
abundance of mRNA was assessed by normalization and calibrated to glyceraldehyde 3-phosphate dehydrogenase (GAPDH). BF Bursa of Fabricius,
BM bone marrow, CT cecal tonsil, DL duodenal loop, LI liver, SP spleen and TH thymus
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activity as previously described [23]. Most of the tested
HDPs showed strong antibacterial activity against E.coli
(Fig. 2a), but 4 peptides AvBD5, -8, -10 and -12, showed
very weak lytic activity at 5 μM. The majority of the
peptides, however, killed more than 80 % of E.coli under
test conditions.
We selected peptides that exhibited strong antimicro-
bial activity at 5 uM (less than 15 % survival rate), and
tested antibacterial activity with lower concentrations of
peptide (0.5, 1, 2.5 and 5 μM). These HDPs killed
bacteria in a dose-dependent manner. Most peptides
produced less than 20 % bacterial survival at low mi-
cromolar concentration (2.5 μM) and AvBD4, AvBD6,
AvBD7, CATH1, CATH2, CATH3 and cNK3 show
very strong antibacterial activity at all concentration
(Fig. 2b). These peptides killed 50 % of bacteria at
very low (0.5 μM) micromolar concentration. AvBD4
and CATH3 displayed the strongest antibacterial effect
among all tested chicken HDPs under test conditions.
These results suggest that all functional peptides from
chicken HDP had effective antibacterial activities under a
broad range of peptide concentrations.
Membrane damage by synthetic peptides
To determine whether chicken HDPs altered the morph-
ology and viability of E. coli, we used four cathelicidin
peptides that have strong antimicrobial activity (Fig. 2).
The damage to E. coli cell membranes after treatment
with peptide was determined with confocal laser scanning
microscopy. In the absence of peptide, most of the E. coli
cells were stained green, indicating an intact membrane.
In the presence of 5 μM peptide treatment, the majority
of E. coli cells were stained red, indicating membrane
damage (Fig. 3). The membrane damage was greater with
CATH2 or CATH3 than with CATH1 or CATHB1, con-
sistent with dose-dependent cell killing data.
Scanning electron microscopy showed that untreated E.
coli cells had normal, intact shape and uniform membrane
surface (Fig. 4a and b). However, after treatment with each
CATH an obvious difference in morphology was observed
(Fig. 4c–j). The treated cells showed shrinkage, were rum-
pled, and lost their regularly arranged surface layer. The
burst and crushed appearing cells were surrounded by
debris. These findings suggest that cathelicidin destroy
bacterial cells via membrane damage.
Fig. 2 Antimicrobial activity of chicken HDPs against E.coli. E. coli (6 × 106) were incubated with indicated amounts of peptide for 2 h and cell viability
was compared to untreated cells. Nineteen chicken HDPs were tested under 5 μM concentrations (a) and 12 HDPs that showed more than 90 % killing
activity in 5 μM treatment were selected for assay at lower concentrations (0.5, 1, 2.5, 5 μM) (b). Each bar represents the mean ± S.D. value of at least
three independent experiments. Non-treated cell considered as 100 % cell viability and peptides treated cell viability was compared and calculated in
percentile. *** indicate p≤ 0.001, ** indicate p≤ 0.01 and * indicate p≤ 0.05
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Discussion
The aim of this study was to enhance understanding of
tissue expression and antibacterial activity of chicken
HDPs and to determine whether chickens can be a source
of bioactive HDPs. As an initial step to understand HDPs,
we examined their tissue expression profile, mainly in
immune organs such as bursa of Fabricius, bone marrow,
spleen and thymus. Cecal tonsil, duodenal loop and liver
were also tested. Like their mammalian counterparts,
avian cathelicidins and β-defensins are derived from bone
marrow and/or epithelial cells. Chicken cathelicidins
CATH1, -2 and -3, are highly expressed in bone marrow
with little to no expression in other tissues. In agreement
with their myeloid origin, CATH1-3 mRNA has been
found abundantly in the bone marrow [36]. On the other
hand, chicken CATHB1 mRNA shows a more restricted
expression pattern, with preferential expression in bursa
of Fabricius.
AvBDs expression is seen mainly in bone marrow for
AvBD1 through 7, which originate from myeloid cells,
and in liver for AvBD8 through 10 and -13. Other
lymphoid tissues did not express AvBDs in significant
amounts. AvBD2 and -4 expression is especially very
weak and is limited to bone marrow and AvBD13 is
weakly detected in liver but hardly detected in other
tissues even with increased PCR cycles relative to the
others. These results are consistent with previous
reports [36, 40]. Only AvBD5 was strongly expressed in
thymus. These results show that the tissue specific
pattern varies across the defensin gene family with some
members showing expression in all tested tissues,
whereas the majority demonstrate more limited expres-
sion patterns which can be divided into three groups.
Seven genes (AvBD1 through 7) are predominantly
expressed in bone marrow, four genes (AvBD8 through
10 and 13) are restricted primarily to liver, and three
(AvBD1, -12 and -14) are expressed in all tested tissues.
NK-lysin showed strong expression in spleen with inter-
mediate expression in bone marrow, intestine and thy-
mus. Consistent with the role of cathelicidins, defensins
and NK-lysin in the first line of host defense, abundant
expression of these genes was detected in bursa and
bone marrow. The transcriptional regulatory mechanism
of these genes during development and under pathogen
infection remains to be demonstrated.
The antibacterial efficacy of several defensins, cathelci-
dins and NK-lysin has been evaluated [2, 9, 23, 36, 40].
Like their mammalian counterparts, most chicken AvBD,
CATHs and NK-lysin are capable of killing bacteria.
Cuperus et al. reviewed antimicrobial activity of avian
HDPs against selected pathogens [41]. Zhang and
Sunkara also reviewed expression, antimicrobial and
immunomodulatory activities of HDPs, but there are no
direct, comprehensive comparisons of major HDPs [30].
Here, we synthesized 19 chicken HDPs and analyzed
antibacterial activity against E. coli in a comprehensive
direct comparison. These peptides differ in net charge
from 0.1 to 10 and also vary in length from 28 to 44
amino acids. They also vary in expected hydrophobicity
from 24 to 61 % (Table 1).
Fig. 3 Escherichia coli viability and membrane damage following treatment with cathelicidins. Membrane damage in E. coli treated with each
synthetic cathelicidin peptide (5 μM) was detected with a LIVE/DEAD BacLight Bacterial Viability Kit. Green fluorescence indicates live bacteria with
intact membranes; red fluorescence indicates dead bacteria with damaged membranes. CATH1 cathelicidin1, CATH2 cathelicidin2, CATH3
cathelicidin3, and CATHB1 cathelicidinB1
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Even though many tested chicken HDPs show varying
efficiencies against pathogens, the majority kill bacteria
at low concentration. AvBD5, -8, -10 and -12 show
minimal killing activity among tested HDPs at less than
5 μM. This is consistent with the previous report that
AvBD8 activity showed 27 μM as lethal dose (LD)50
against E.coli [42]. These four peptides have very low
net charge from 0.1 to 1.8. AvBD4 has 24 % hydro-
phobicity with 5.8 net charge and can kill bacteria
very well compared to AvBD5, -8 and -13 that have
the same hydrophobicity but lower cationicity of 0.1
to 4. This suggests that low net charge results in
Fig. 4 Scanning electron micrographs of cathelicidin-induced cell membrane damage. Scanning electron micrographs of E. coli with no treatment
(control, a and b) or treated with cathelicidin1 (CATH1, c and d), cathelicidin2 (CATH2, e and f), cathelicidin3 (CATH3, g and h), or cathelicidinB1
(CATHB1, i and j). The rectangle as shown in the large-scale image
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inefficient antibacterial efficacy, even with a suitable
hydrophobicity. However, AvBD3, -4 and -6 have the
same net charge (5.8) and these peptides kill effect-
ively over all tested concentrations, although BD4 has
33 % hydrophobicity and the strongest activity among
the three. Also, there is 6 % gap in hydrophobicity
between AvBD2 and cNK3, which share 3.9 net
charge but demonstrate different activity. This result
suggests that, hydrophobicity is an important factor
in antibacterial activity of peptides. A structural effect
cannot be ruled out but this result revealed that anti-
microbial activity is strongly influenced by cationicity
and hydrophobicity. Although, the CATH family has
more overall cationicity and hydrophobicity than the
AvBD family, but this does not translate to higher
antibacterial activity. The C-terminus of some of our
synthesized peptides was abbreviated relative to nat-
ural peptides. We recognize that this could impact
cationicity and hydrophobicity on antibacterial activ-
ity. This potential discrepancy should be clarified in
future experiment.
In the present study, all four CATHs reduced E. coli
cell viability and severely damaged E. coli cell mem-
branes, with CATH2 and CATH3 showing the highest
efficiency. In previous studies, the variable domains of
CATH1, CATH2, and CATH3 were clearly discrimi-
nated, but the variable domain of CATHB1 was not
identified [35, 36]. Here, we predicted the variable
domain sequence of CATHB1 and demonstrated weak
antibacterial activity compared to others.
Mechanisms for bacteria killing by β-defensin are
thought to be similar to those of other cationic HDPs
where positively charged residues interact with negatively
charged membrane components, after which hydrophobic
residues insert into the membrane, disrupting it and
killing the cells [43, 44]. It is generally accepted that
increasing the hydrophobicity of the nonpolar face of the
amphipathic α-helical peptides will also increase the anti-
microbial activity [45, 46]. Increased cationicity also helps
to enhance antibacterial activity [9]. Cationicity is import-
ant for killing bacteria [47], but simply increasing the net
charge does not result in the improvement of antimicro-
bial potency [48]. Hydrophobicity also requires an optimal
range to enhance antibacterial activity [45]. Disruption of
structural integrity is another important factor for high
efficiency in bacteria killing [49, 50]. Our results indicate
that the mode of antibiotic action of HDPs requires a
balance between cationicity and hydrophobicity to
optimize bacteria killing activity. But the relationships
between two important factors, cationicity and hydro-
phobicity, and antimicrobial efficacy of HDPs remains
to be determined. Antimicrobial efficacy of 19 pep-
tides against E.coli in this study are consistent with
the previous report [35]. Future study against other
bacteria that cause bacterial disease in birds will help
to improve our understanding of the role of these
genes in immunity to bacteria in chickens.
Conclusions
Antimicrobial activity and differential tissue expres-
sion patterns of 19 chicken HDPs were analyzed. In
summary, we confirmed that most of the HDPs
showed antibacterial activity against E.coli and dem-
onstrate their differential tissue expression pattern.
These studies highlight the dose-dependent antimicro-
bial effects that were mediated by membrane damage
and the importance of balance between cationicity
and hydrophobicity. Gene expression of chicken HDPs
are variable and the AvBD gene family can be divided
into two functional expressional groups.
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